KRAS and neoplasm: By integrating several publicly available datasets that couple KRAS dependencies, genomic features, and tumor-specific transcriptional profiles, we have developed an integrated model (henceforth the K20 model) that improves prediction of KRAS dependency beyond the presence of an activating KRAS mutation.